Children's Hospital of Philadelphia — Philadelphia, Pennsylvania

Public research footprint of Children's Hospital of Philadelphia, compiled from the ClinicalTrials.gov public registry.

2,069

Registered studies

630

Active

363

Recruiting now

1,181

Completed

201

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · B Acute Lymphoblastic Leukemia · Spindle Cell Rhabdomyosarcoma · Pediatric Pyruvate Kinase Deficiency

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Children's Hospital of Philadelphia?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.